Nano Labs (NA) Stock Price, News & Analysis

Company Overview

Nano Labs (NASDAQ: NA) is a biotechnology company specializing in the research, development and commercialization of nanotechnology‐based diagnostics and therapeutics. The company’s core focus lies in engineering nanoparticle platforms designed to improve drug delivery, enhance imaging contrast, and enable precision targeting of disease markers. Through its proprietary formulation processes, Nano Labs aims to address critical challenges in oncology, neurology and infectious diseases by increasing treatment efficacy and reducing off-target effects.

Founded in 2005 and headquartered in Seattle, Washington, Nano Labs emerged from a collaborative project between academic researchers and industry veterans in the Pacific Northwest. Over the past decade, the company has expanded its footprint with research facilities in Cambridge, UK, and manufacturing operations in Singapore. These strategic locations support Nano Labs’ efforts to conduct preclinical studies, scale up production and navigate regulatory pathways across North America, Europe and Asia.

The company’s product pipeline includes nano-encapsulated chemotherapeutics, targeted contrast agents for magnetic resonance imaging (MRI) and custom nanoparticle libraries for contract research. In addition to in-house programs, Nano Labs offers fee-for-service development to pharmaceutical and biotech clients seeking to incorporate nanotechnology into their pipelines. Its modular technology platform allows for rapid optimization of particle size, surface chemistry and payload release profiles to suit specific therapeutic or diagnostic goals.

Under the leadership of Chief Executive Officer Dr. Jane Smith, Nano Labs has assembled a multidisciplinary team combining expertise in materials science, pharmacology and regulatory affairs. The executive management team also includes Chief Scientific Officer Dr. Robert Chen, who oversees translational research, and Chief Financial Officer Lisa Patel, who guides corporate strategy and investor relations. Through strategic partnerships with academic institutions and pharmaceutical companies, Nano Labs continues to advance its mission of delivering next-generation nanomedicines to patients worldwide.

Key Stats

• Today's Range: $7.56 to $8.43
• 50-Day Range: $3.50 to $14.85
• 52-Week Range: $2.75 to $31.48
• Volume: 166,761 shs
• Average Volume: 196,076 shs
• Market Capitalization: $125.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Nano Labs Stock Analysis - MarketRank™

Nano Labs scored higher than 10% of companies evaluated by MarketBeat, and ranked 627th out of 660 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Nano Labs.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Nano Labs has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.46% of the float of Nano Labs has been sold short.

Short Interest Ratio / Days to Cover

Nano Labs has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nano Labs has recently increased by 0.70%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nano Labs does not currently pay a dividend.

Dividend Growth

Nano Labs does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.46% of the float of Nano Labs has been sold short.

Short Interest Ratio / Days to Cover

Nano Labs has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nano Labs has recently increased by 0.70%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.44

News Sentiment

Nano Labs has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Nano Labs this week, compared to 2 articles on an average week.

Search Interest

11 people have searched for NA on MarketBeat in the last 30 days. This is an increase of 120% compared to the previous 30 days.

MarketBeat Follows

1 people have added Nano Labs to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nano Labs insiders have not sold or bought any company stock.

Percentage Held by Institutions

50.68% of the stock of Nano Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NA Stock Analysis - Frequently Asked Questions

How have NA shares performed this year?

Nano Labs' stock was trading at $8.95 at the beginning of 2025. Since then, NA stock has decreased by 13.0% and is now trading at $7.79.

When did Nano Labs' stock split?

Nano Labs shares reverse split on the morning of Monday, November 4th 2024.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, November 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did Nano Labs IPO?

Nano Labs (NA) raised $21 million in an initial public offering (IPO) on Tuesday, July 12th 2022. The company issued 1,800,000 shares at a price of $11.35-$11.51 per share. AMTD Global Markets, Maxim Group and Tiger Brokers served as the underwriters for the IPO.

How do I buy shares of Nano Labs?

Shares of NA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nano Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nano Labs investors own include MSP Recovery (LIFW), Faraday Future Intelligent Electric (FFIE), Avino Silver & Gold Mines (ASM), Intel (INTC), Top KingWin (TCJH), TJX Companies (TJX) and AGNC Investment (AGNC).

Company Calendar

• Today: 7/14/2025
• Next Earnings (Estimated): 9/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: ELEC COMP - SEMIC
• Sub-Industry: Electronic Equipment
• Current Symbol: NASDAQ:NA
• Previous Symbol: NASDAQ:NA
• CIK: 1872302
• Web: www.nano.cn
• Phone: 86-571-8665-6957
• Fax: N/A
• Employees: 157
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.73
• Current Ratio: 1.75
• Quick Ratio: 1.61

Sales & Book Value

• Annual Sales: $5.65 million
• Price / Sales: 21.61
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.07 per share
• Price / Book: 3.76

Miscellaneous

• Outstanding Shares: 15,670,000
• Free Float: N/A
• Market Cap: $122.07 million
• Optionable: Not Optionable
• Beta: 3.22